NCT04162873 2025-02-12Celecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck CancerUniversity of UtahPhase 2 Terminated13 enrolled 36 charts
NCT00052611 2018-03-29Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck DysplasiaDana-Farber Cancer InstitutePhase 2 Completed23 enrolled
NCT00970502 2017-04-10Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck CancerIcahn School of Medicine at Mount SinaiPhase 1/2 Completed15 enrolled 16 charts